Prof. Reem Hanna (BDS, PhD, MSc, PG DipSed, PG DipHE, PG Cert.AP, FAHE, FRSM, FIADFE) is a Consultant Specialist Oral Surgeon and Honorary Associate Professor at the UCL Eastman Dental Institute, UCL, UK, where she is Academic Director and Lead for CPD Programmes in Laser Dentistry and Photobiomodulation (PBM). She also holds Honorary Associate Professorships at UCL and is Academic Professor at the University of Genoa, Italy. Prof. Hanna is Scientific Director and Executive Board Member of the World Association for Photobiomodulation Therapy (WALT), and Scientific Co-chair and Executive Board Member of the British Medical Laser Association (BMLA). Her research focuses on PBM and antimicrobial photodynamic therapy in oncology-related oral complications, neuropathic pain and regenerative medicine. She has led international consensus initiatives, including the 2026 WALT Position Paper on PBM dosimetry for orofacial neuropathic pain, and serves as Chief and Principal Investigator for translational research establishing standardised PBM dosimetry for bone regeneration. She has authored over 70 peer-reviewed publications and book chapters, with more than 1,700 citations. She received the European Medical Laser Association Life Achievement Award (2022, 2026) and the 2024 WALT Award for Clinical Scientific Research.
Prof. Reem Hanna (BDS, PhD, MSc, PG DipSed, PG DipHE, PG Cert.AP, FAHE, FRSM, FIADFE) is a Consultant Specialist Oral Surgeon and Honorary Associate Professor at the UCL Eastman Dental Institute, UCL, UK, where she is Academic Director and Lead for CPD Programmes in Laser Dentistry and Photobiomodulation (PBM). She also holds Honorary Associate Professorships at UCL and is Academic Professor at the University of Genoa, Italy. Prof. Hanna is Scientific Director and Executive Board Member of the World Association for Photobiomodulation Therapy (WALT), and Scientific Co-chair and Executive Board Member of the British Medical Laser Association (BMLA). Her research focuses on PBM and antimicrobial photodynamic therapy in oncology-related oral complications, neuropathic pain and regenerative medicine. She has led international consensus initiatives, including the 2026 WALT Position Paper on PBM dosimetry for orofacial neuropathic pain, and serves as Chief and Principal Investigator for translational research establishing standardised PBM dosimetry for bone regeneration. She has authored over 70 peer-reviewed publications and book chapters, with more than 1,700 citations. She received the European Medical Laser Association Life Achievement Award (2022, 2026) and the 2024 WALT Award for Clinical Scientific Research.